A metabolomic approach to identifying platinum resistance in ovarian cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1757-2215
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
A metabolomic approach to identifying platinum resistance in ovarian cancer ; volume:8 ; number:1 ; day:26 ; month:3 ; year:2015 ; pages:1-14 ; date:12.2015
Journal of ovarian research ; 8, Heft 1 (26.3.2015), 1-14, 12.2015

Urheber
Poisson, Laila M.
Munkarah, Adnan
Madi, Hala
Datta, Indrani
Hensley-Alford, Sharon
Tebbe, Calvin
Buekers, Thomas
Giri, Shailendra
Rattan, Ramandeep
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13048-015-0140-8
URN
urn:nbn:de:101:1-2021080719400449303979
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:58 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Poisson, Laila M.
  • Munkarah, Adnan
  • Madi, Hala
  • Datta, Indrani
  • Hensley-Alford, Sharon
  • Tebbe, Calvin
  • Buekers, Thomas
  • Giri, Shailendra
  • Rattan, Ramandeep
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Platinum resistance in breast and ovarian cancer cell lines

Platinum resistance in breast and ovarian cancer cell lines

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy

Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining

Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining

Plasma metabolomic characterization of premature ovarian insufficiency

Plasma metabolomic characterization of premature ovarian insufficiency

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer

Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer

C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation

C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer

Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer

Related Clinical Factors of Platinum-Based Chemotherapy Resistance in Patients with Epithelial Ovarian Cancer

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

Verbundene Objekte